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Abstract  Hypertension is a health problem that has increasing prevalence worldwide. Antihypertensive medications are 
the key for achieving controlled blood pressure. Little is known about predictors of antihypertensive medications adherence 
in Saudi Arabia. This is a cross-sectional study of 308 participants from a general hospital in Jeddah city, Saudi Arabia 
conducted between July 2013 and February 2014. Out of the 308 participants, the results showed that 27.9% were classified 
as perfect adherents and 72.1% were classified as non-perfect adherents to antihypertensive medications. Significant 
predictors of non-perfect antihypertensive medications in this study were having non-formal education (p=0.031, OR=2.3, 
95%CI = [1.82-5]), reporting a poor relationship with physicians (p=0.004, OR=2.25, 95%CI= [1.29-3.9]), and having no 
co-morbidities (p=0.048, OR=1.86, 95%CI [1.00-3.46]). The outcome of this study highlights the need for policies and 
interventions that enhance the level of formal education at a population level and improve physician-patient relationships in 
health care settings. 
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1. Introduction 
Hypertension is a global health problem, and its 
prevalence is still increasing. In 2000, it was estimated that 
one billion people suffered from hypertension, and this 
number is predicted to increase to 1.56 billion by 2025 
(Kearney et al., 2005). Follow-up and medication 
adjustments should continue until the goal of blood pressure 
(BP) lower than 140/90 mmHg is achieved. This is the level 
required to decrease the risk of cardiovascular disease 
complications. The goal for patients with hypertension and 
co-morbidities such as diabetes or renal disease is to achieve 
a BP lower than 130/80 mmHg. Follow-up visits for stable 
individuals who have reached their BP goals usually occur at 
3 to 6-month intervals (Chobanian et al., 2003). 
The use of antihypertensive medications is a key 
component of the long-term approach to controlling BP 
levels. The effectiveness of antihypertensive treatment is 
well established and has been quantified in terms of overall 
reduction in the relative risk of stroke and other 
cardiovascular disease events as well as lower healthcare 
costs (Dragomir et al., 2010). Adherence to antihypertensive 
medication is an effective step for controlling blood pressure 
and preventing complications. Low-adherent patients have a  
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higher risk of cardiovascular events than high-adherent 
patients (Mazzaglia et al., 2009). A cohort study of 59,647 
hypertensive patients living in Quebec, Canada, showed that 
poor adherence to antihypertensive medication is correlated 
to a high risk of hospitalization and higher healthcare costs, 
which could be as much as USD $3,574 (95% CI, 
$2897–$4249) per person within a three-year period 
(Dragomir et al., 2010). 
There are several factors that affect a hypertensive 
patient’s behavior regarding adherence to antihypertensive 
treatments. These factors can be categorized as: (1) 
patient-related factors such as socio-demographics, beliefs 
about treatment and knowledge about hypertension and its 
treatment; and (2) patient-provider factors such as the 
patient-provider relationship and the support received from 
healthcare services (Van der Feltz-Cornelis, Van Oppen, 
Van Marwijk, De Beurs, & Van Dyck, 2004).  
A study of 250 Iranian patients in Shiraz investigating the 
impact of socio-demographic factors on their medication 
adherence found that patients who were older than 45 years 
were more likely to adhere to antihypertensive regimens and 
also to have better knowledge of their condition compared to 
those who had low knowledge about their health condition 
(Hadi & Rostami-Gooran, 2004). There is a positive 
relationship between levels of adherence and knowledge 
regarding treatment (Hayrettin et al., 2009). In a study in 
Saudi Arabia, it was found that 43.7% of 190 patients 
believed they could stop taking antihypertensive drugs once 
their blood pressure had stabilized. This demonstrates how a 
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lack of knowledge and information regarding treatment can 
contribute to patient non-adherence (Al-Sowielem & 
Elzubier, 1998). 
When patients have positive beliefs regarding the efficacy 
of their treatment and also trust that their medication is 
working well to control their illness, their adherence often 
improves (Fraser, Hadjimichael, & Vollmer, 2001; 
Holzemer et al., 1999). On the contrary, believing that 
medications are not important or are harmful is a barrier to 
adherence (Cohen, Rogers, Burke, & Beilin, 1998). The 
belief that taking antihypertensive medication will result in 
side effects is common among hypertensive patients (Cohen 
et al., 1998). Importantly, patients’ beliefs about medical 
management, and about drugs in particular, are not 
necessarily associated with their religious beliefs 
(Al-Sowielem & Elzubier, 1998) or cultural background  
(Li, Stewart, Stotts, & Froelicher, 2006).  
The presence of co-morbidities or uncontrolled blood 
pressure that requires a complex drug regimen can affect 
patients’ medication adherence. When compared with 
complex drug regimens, simpler regimens have been found 
to be associated with greater levels of patient adherence 
(Iskedjian et al., 2002). Furthermore, poor control of 
hypertension results in more frequent physician visits and 
higher drug costs (Paramore et al., 2001). The costs of 
medications have an inverse relationship with medication 
adherence (Paramore et al., 2001). The more expensive the 
medication, the less chance that some patients would be able 
to afford it. This results in poor blood pressure control due to 
no available treatment. 
Health education resources such as patient education 
sessions and written patient education materials, are 
provided by the healthcare system to enhance treatment 
practices. The aim of providing such resources is to increase 
patient knowledge about their health condition and the 
required management. However, compared to no active 
intervention, the clinically significant effect of printed 
educational materials on adherence appears to be minor 
(Farmer et al., 2008).  
The level of satisfaction and degree of autonomy patients 
experience when they deal with healthcare providers is 
determined by the quality of the therapeutic relationship 
(Armstrong, 2010). Patients may perceive that the healthcare 
environment is not therapeutic if they feel dissatisfied with 
their relationship with healthcare providers. Poor 
relationships between patients and healthcare providers 
decrease patient empowerment and lead to lower levels of 
medication adherence (Safeer & Keenan, 2005). 
To date, limited literature exists on medication adherence 
and its predictors among antihypertensive patients in Saudi 
Arabia (AL-Rukban, Al-Sughair, Al-Bader, & Al-Tolaihi, 
2007; Al-Sowielem & Elzubier, 1998; AlNozha, Ali, & 
Osman, 1997). Compliance to antihypertensive treatments 
was assessed in a cross-sectional study of 190 patients 
attending primary health care in Saudi Arabia. The results 
showed that 34.2% of patients were compliant with the 
recommended treatment (Al-Sowielem & Elzubier, 1998). A 
2007 study which focused on the management of 
hypertension for Saudi patients receiving primary health care, 
reviewed the medical records of 201 patients and found that 
only 25% showed a controlled blood pressure. Findings from 
this study reflected inadequate physician practice with 
respect to patients with hypertension (AL-Rukban et al., 
2007). In another study, a population-based cross-sectional 
survey of 13,700 hypertensive patients in Saudi Arabia 
reported that the prevalence of isolated systolic hypertension 
(ISH), isolated diastolic hypertension (IDH) and systolic 
diastolic hypertension (SDH) among adults above 18 years 
was 1.8%, 3.8% and 3.5%, respectively (AlNozha et al., 
1997).  
This paper reports on the findings of a study conducted 
between 2013 and 2014 which examined the levels of 
medication adherence and its predictors among 308 
hypertensive patients attending outpatient clinics in a general 
hospital in Saudi Arabia. 
2. Materials and Method 
Ethical approval was gained from the Queensland 
University of Technology Human Research Ethics 
Committee in Brisbane, Australia (approval number 
1200000522) and King Fahad General Hospital in Jeddah, 
Saudi Arabia (approval number 00163).  
2.1. Study Population and Eligibility Criteria  
The inclusion criteria for this study were (1) adult patients 
aged 18 years or older attending the outpatient clinics at King 
Fahad General Hospital (Jeddah city, Saudi Arabia); (2) who 
had a diagnosis of hypertension and had started their 
antihypertensive medication more than six months ago. 
Individuals who had been diagnosed with hypertension 
within the previous six months were excluded as they were 
likely to require frequent monitoring for medication 
adjustment to achieve a stable BP.  
2.2. Study Design 
This cross-sectional study was conducted between July 
2013 and February 2014. A total of 308 hypertensive patients 
were interviewed during the clinic hours (8 am to 2 pm 
weekdays) at the outpatient department, King Fahad General 
Hospital in Jeddah city. Convenience sampling was used by 
approaching all patients who visited outpatient clinics 
(cardiology, endocrinology, and internal medicine) for 
follow up with the treating physicians. Patients were invited 
to participate while visiting the nursing room to complete the 
initial assessment (pulse, blood pressure, temperature) prior 
to their medical appointment. The principal researcher 
explained the study to potential participants and those who 
agreed to participate were asked to sign a consent form. 
Participants completed a self-administered questionnaire in 
the waiting area after they completed their clinic visits; the 
principal researcher was available to answer any inquiries. 
For patients who could not read or write, the principal 
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researcher and research assistants (two of the staff nurses in 
the treatment room) assisted them by reading the survey 
questions and response categories, and recording their 
answers in the questionnaire. 
2.3. Research Instrument  
The instruments used to assess adherence to 
antihypertensive treatment and its related factors are shown 
in Table 1. To measure adherence level, an Arabic version of 
the Hill-Bone questionnaire was used. The Arabic version 
was validated in a previous study reporting a Cronbach’s 
alpha of 0.76 (Alsolami, 2013). It includes nine questions 
with four response categories ranging from 1 = None of the 
time to 4 = All of the time.  
Based on the existing literature, items assessing key 
factors related to antihypertensive treatment adherence were 
also included in the questionnaire. These factors assessed 
knowledge of hypertension and hypertension treatment 
(Karaeren et al., 2009), medication beliefs (Horne, Weinman, 
& Hankins, 1999), physician-patient relationship (Chin, 
2001) and the level of healthcare support (Ogedegbe et al., 
2012). All these items used five point Likert scale responses 
(1= very bad to 5 = very good) (Horne et al., 1999). All 
instruments reported high reliability scores (Table 1). 
3. Statistical Analysis  
Descriptive statistics were used to summarize the 
socio-demographic, health-related and adherence-related 
variables. Bivariate analyses using the Pearson’s Chi-square 
test were employed to assess the association between the 
outcome measure (level of adherence) and each of the 
socio-demographic, health-related, and adherence-related 
variables. Adherence level was dichotomized into perfect 
adherence and imperfect adherence by grouping and coding 
the responses for “some of the time, most of the time and all 
of the time” as imperfect adherence, and “none of the time” 
responses as perfect adherence, based on a previous study 
that used the Hill-Bone questionnaire (Koschack, Marx, 
Schnakenberg, Kochen, & Himmel, 2010). 
Binary logistic regression analysis using the backward 
stepwise likelihood-ratio method was used to assess the 
predictors of adherence controlling for the 
socio-demographic factors (gender, age, marital status, 
education status, employment status, smoking status, income, 
and time since diagnosis of hypertension) which were fixed 
into the model. The final binary logistic regression model 
includes all the socio-demographic factors and the 
significant predictors of adherence. The alpha level of 
significance for all inferential statistics was set at 0.05. 
Overall model fit was estimated using the R2 statistic. SPSS v. 
21 (SPSS IBM Statistics) was used to conduct all statistical 
analyses. 
4. Results  
Of the 347 questionnaires that were distributed, 316 were 
returned, for a response rate of 85%. Eight of the returned 
questionnaires were incomplete and therefore this analysis is 
based on 308 completed questionnaires. 
Table 1.  Instruments used to assess adherence to antihypertensive treatment and its associated factors 
Instruments Items Cronbach’s alpha 
Hill-Bone Medication 





3 items: knowledge about hypertension as chronic condition, 
normal level of hypertension, symptoms of high blood pressure. 0.80 
4 items: consequences of untreated hypertension benefit of blood 






5 items: necessity of blood pressure control treatment, perception of 
health if blood pressure control treatment is not taken, perception of 
future health, preventing from bad consequences. 
0.80 
6 items: concern of long term use of blood pressure control 
treatment, concern of reliance on blood pressure control treatment. 0.88 
Patient-physician 
relationship 
9 items: physician help, time, trust, understanding, dedication, 
agreement, communication, satisfaction, accessibility. 0.88 
Health care support 
6 items: health care overall support, hospital support, patient 
education, patient resources, medications refill, necessity to 
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Table 2.  Participants’ socio-demographic and health-related 
characteristics (n=308) 








18 – 30 


































Income (per month) 
< 5,000 SR* 
5,000 – 10,000 SR 





Time since diagnosis of hypertension 
> 6 months to < 1 year 
1 to 3 years 











































Received Healthcare support 
Low healthcare support 
High healthcare support 
149 (48.4) 
159 (51.6) 
Medication Reminder Aids 
Use aids 




*SR = Saudi Riyal 
4.1. Participant’s Characteristics  
The socio-demographic, health-related and 
adherence-related characteristics of participants in this study 
are shown in Table 2. The majority of participants were male 
(56.8%), older than 45 years (77.6%), married (78.2%), with 
non-formal education (84.7%), and non-smokers (83.4%). 
Those with non-formal education were mostly older patients 
who came to Jeddah city originally from rural villages and 
were illiterate or had learned basic reading and writing skills 
at the mosques. Almost half of respondents had an income 
lower than 5,000 Saudi Riyals [$1,350 USD].  
Regarding health and adherence-related factors, two thirds 
of participants had a diagnosis of hypertension for more than 
three years, about one third had comorbidities and were 
taking other medications, one in four had low knowledge of 
hypertension or antihypertensive medications, and just over 
half reported high necessity of and high concern about their 
antihypertensive medications, and good relationship with 
their physicians. Less than half of respondents used 
medication reminder aids. 
4.2. Adherence Level  
Table 3 reports the frequency of responses to the 
Hill-Bone scale items. The results show that out of the 308 
patients who participated in this study, 27.9% were classified 
as reporting perfect adherence and 72.1% were classified as 
non-perfect adherence (Song et al., 2011).  
4.3. Bivariate Analysis  
Table 4 shows the bivariate associations between the level 
of adherence and each of the socio-demographic, health- and 
adherence-related factors. The bivariate analyses found that 
level of education, beliefs about medication (concern), the 
physician-patient relationship and co-morbidities were 
significantly associated to level of adherence. The odds of 
reporting none perfect adherence to antihypertensive 
treatments were 2.3 times greater among non-formally 
educated patients compared to those who received formal 
education, 1.89 times greater among patients who reported 
high level of concern about taking the medications compared 
to those with low concern, 2.25 times greater for those who 
reported poor relationship with their physicians compared to 
those who reported good relationship with their physicians 
and 1.86 greater with patients who only hypertension as a 
health condition to those with other co-morbidities.  
4.4. Regression Analysis   
A binary logistic regression analysis was performed to 
assess the predictors of medication adherence. All socio 
demographic characteristics were fixed in the model. The 
final model (Table 5) includes the socio-demographic 
characteristics and all the factors that reported significance 
(p<0.05). The Nagelkerke R2 was 0.096. Table 5 shows that 
having non-formal education (p=0.031, OR=2.3, 95%CI = 
[1.82-5]), reporting a poor relationship with their physicians 
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(p=0.004, OR=2.25, 95%CI= [1.29-3.9]), and having no 
co-morbidities (p=0.048, OR=1.86, 95%CI [1.00-3.46]) 
were significant predictors of non-perfect adherence, after 
controlling for all the other factors in the model. 
Table 3.  Frequency of responses to Hill-Bone scale items (n=308) 
 Responses categories % 
Scale item None of the time (1) 
Some of the 
time (2) 
Most of the 
time (3) 
All of the 
time (4) 
1- How often do you forget to take your High Blood Pressure (HBP) medicine? 47.7 45.5 4.2 2.6 
2- How often do you decide not to take your HBP medicine? 62.7 23.1 10.4 3.9 
3- How often do you forget to get your prescription filled? 75.6 16.2 5.2 2.9 
4- How often do you run out of HBP pills? 58.1 26.3 5.5 10.1 
5- How often do you skip your HBP medicine before you go to the doctor? 62.7 26 7.8 3.6 
6- How often do you miss taking your HBP pills when you feel better? 79.2 14.9 3.6 2.3 
7- How often do you miss taking your HBP pills when you feel sick? 84.4 12 2.3 1.3 
8- How often do you take someone else’s HBP pills? 92.9 4.9 1.6 0.6 
9- How often do you miss taking your HBP pills when you are careless? 74.7 20.5 3.2 1.6 
Table 4.  Bivariate analysis for the level of adherence and its related factors 
 
Adherence Level χ2  Tests 
Perfect Adherence Non-Perfect Adherence Pearson χ2 
P value (2 
sided) 
OR [95% CI] 
 Frequency (%) Frequency (%) 
Gender 
Male 49 (28.0) 126 (72.0) 
0.972 1.00 [0.61-1.66] 
Female 37 (27.8) 96 (72.2) 
Age 
45 and less 18 (26.1) 51 (73.9) 
0.700 0.88 [0.48-1.62] 
>45 68 (28.5) 171 (71.5) 
Marital status 
Married 72 (29.9) 169 (70.1) 
0.147 1.61 [0.84-3.09] 
Non-Married 14 (20.9) 53 (79.1) 
Education Status 
Formal Education 19 (40.4) 28 (59.6) 
0.038 1.96 [1.03-3.74] 
Non-formal Education 67 (25.7) 194 (74.3) 
Employment status 
Employed 33 (25.2) 98 (74.8) 
0.358 1.26 [0.76-2.11] 
Non-Employed 53 (29.9) 124 (70.1) 
Smoking status 
Smoker 15 (29.4) 36 (70.6) 
0.795 1.09 [0.56-2.11] 
Non-Smoker 71 (27.6) 186 (72.4) 
Income 
<1350 USD 44 (30.3) 101 (69.7) 
0.408 1.23 [0.74-2.03] 




3 years and less 30 (27.8) 78 (72.2) 
0.967 0.98 [0.58-1.66] 
>3 years 56 (28.0) 144 (72.0) 
Co-morbidities 
With other disease 36 (33.6) 71 (66.4) 
0.050 1.53 [0.91-2.55] 
Only hypertension 50 (24.9) 151 (75.1) 
Other medications 
Take other medications 36 (33.3) 72 (66.7) 
0.120 1.50 [0.89-2.50] 
Only antihypertensive 50 (25.0) 150 (75.0) 
Knowledge 
Low Knowledge 27 (31.4) 52 (23.4) 
0.151 1.49 [0.86-2.59] 
High knowledge 59 (68.6) 170 (76.6) 
Beliefs of medication 
use (necessity) 
Low necessity 35 (24.5) 108 (75.5) 
0.209 1.38 [0.83-2.28] 
High necessity 51 (30.9) 114 (69.1) 
Beliefs of medication 
use (concern) 
Low concern 48 (35.0) 89 (65.0) 
0.013 1.88 [1.14-3.12] 
High concern 38 (22.2) 133 (77.8) 
Physician-Patient 
Relationship 
Good relationship 57 (35.4) 104 (64.6) 
0.002 2.23 [1.32-3.74] 
Poor relationship 29  (19.7) 118 (80.3) 
Received Healthcare 
Support 
Low healthcare support 34 (22.8) 115 (77.2) 
0.053 0.60 [0.36-1.00] 
High healthcare support 52 (32.7) 107 (67.3) 
Use of medication aids 
No medication aid 45 (25.6) 131 (74.4) 
0.288 1.31 [0.79-2.16] 
Medication aid 41 (31.1) 91 (68.9) 
 
186 Fatmah Alsolami et al.:  Factors Affecting Antihypertensive Medications   
Adherence among Hypertensive Patients in Saudi Arabia 
Table 5.  Predictors of antihypertensive medication adherence* 
Predictors 
(R2 = 0.096) 
B Odds Ratio 
95% CI limit 
P-value 
Lower Upper 
Gender (Female) 0.037 1.04 0.55 1.96 0.908 
Age (>45 years) 0.081 1.08 0.50 2.35 0.838 
Marital status (Non- married) 0.690 1.99 0.96 4.13 0.064 
Education status (Non-formal education) 0.921 2.51 1.19 5.32 0.016 
Employment status (Employed) 0.296 1.34 0.71 2.56 0.367 
Smoking status (Non-smoker) 0.287 1.33 0.65 2.74 0.436 
Income (1,350 USD or more) 0.111 1.12 0.64 1.95 0.696 
Time since Diagnosis (3 years or less) 0.038 1.04 0.55 1.94 0.907 
Co-morbidities (Only hypertension) 0.641 1.90 1.04 3.46 0.036 
Physician-patient relationship (Poor relationship) 0.759 2.14 1.25 3.65 0.005 
*Non-perfect adherence is the response category and perfect adherence is the reference category 
5. Discussion  
For patients with high blood pressure, adherence to 
medication is a significant factor in preventing damaging 
complications to body systems. The literature has identified 
several factors that contribute to a lack of adherence to 
antihypertensive medication in hypertensive patients such as 
socio-demographic characteristics, physician-patient 
relationship and health care support. Addressing these 
factors is a significant step towards the successful control 
and management of hypertension. 
Very limited research has investigated adherence to 
antihypertensive medication and its associated factors in 
Middle Eastern countries in general and in Saudi Arabia in 
particular. The present study has addressed this research gap 
by investigating the levels of medication adherence and its 
predictors among 308 hypertensive patients attending an 
outpatient hospital clinic in Jeddah City, Saudi Arabia.  
In our study, 72% of the participants reported non-perfect 
adherence to their medications. These results are higher than 
those from previous studies conducted in Tabuk City, Saudi 
Arabia (47.0%) (Khalil & Elzubier, 1997), Palestine (54.2%) 
(Al-Ramahi, 2013), Egypt (25.9%) (Youssef & Moubarak, 
2002) and Pakistan (64.7%) (Saleem et al., 2012). The 
difference in our results can be explained by the different 
methodologies used, study population and settings. Previous 
studies used yes/no responses for adherence questions (Song 
et al., 2011), which reduces the range of responses for 
participants. Other studies used the pill-counting method 
(Chin, 2001) and pharmacy records (Koschack et al., 2010). 
The results from the current study are based on patients’ 
self-reports using a Likert (Hill-Bone) scale to assess 
medication adherence. This scale has been developed 
specifically to measure the level of adherence for 
hypertensive patients (Lambert et al., 2002). The scale 
testing reported high level of validity and reliability in 
different studies (Kim, Hill, Bone, & Levine, 2000; Lambert 
et al., 2002; Song et al., 2011). 
This study focused on both patient- and patient-provider 
related factors and found that non-formal education, absence 
of co-morbidities, and poor physician-patient relationship 
were significant predictors of non-perfect adherence.  
The significant association found between patients’ 
education level and medication adherence is in line with 
previous studies in Saudi Arabia and internationally (Baune, 
Aljeesh, & Bender, 2005; Hashmi et al., 2007), where 
patients with formal education reported a higher level of 
medication adherence compared to those with non-formal 
education. Patients with greater levels of formal education 
may have a better understanding of the goal of controlling 
their blood pressure, the consequences of poor adherence 
and the potential side effects associated with 
antihypertensive treatments. 
We also found that the absence of co-morbidities 
predicted non-perfect adherence among this group of 
patients. Similarly, previous studies in the U.S. found that 
patients with both hypertension and diabetes were more 
likely to adhere to multiple medications (An & Nichol, 2013; 
Loeppke et al., 2011). This is because of their experience 
with multiple symptoms from hypertension and other 
co-morbid conditions which requires them to adhere to their 
medications to relieve these symptoms.  
Consistent with previous studies (Aljumah, Ahmad, & 
AlQhatani, 2014), we found a significant association 
between poor physician-patient relationship and non-perfect 
medication adherence. Good physician-patient relationship 
is associated with better medication adherence. In the 
outpatient clinics in general hospitals in Saudi Arabia, there 
is very limited chance for patients to be seen by the same 
physician on every visit, as consultations may be provided by 
a number of physicians or medical graduates under the 
supervision of a senior physician. Given the high volume of 
consultations, patients who wish to be seen by the same 
physician are likely to be placed on a waiting list. Lack of 
continuity of care prevents the establishment of quality 
long-term relationships between patients and healthcare 
providers. According to Thom and other colleagues, building 
physician-patient trust is underpinned by patient’s receiving 
clear communication and the expectation of a long-term 
relationship (Thom, Kravitz, Bell, Krupat, & Azari, 2002). 
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Although some attempts have been made to explore 
physician-patient communication in Saudi Arabia, there is a 
scarcity of quality research investigating this issue and its 
impact on medication adherence. This is an important gap 
given the potential impact of culture, education and health 
beliefs on the quality of physician-patient relationships.  
The findings of our study showed that patient’s beliefs 
about antihypertensive medications were not significant 
predictor of medications adherence. Patients’ knowledge 
about their health condition tends to determine their beliefs 
about treatment and medication, and when healthcare 
providers fail to provide relevant information or education 
support to hypertensive patients related to the medications, 
patients’ beliefs about the necessity of taking medications 
decreases and their level of concern increases. 
Our results showed a not statistically significant 
association between knowledge of hypertension and 
antihypertensive treatment, and medication adherence. This 
is contrary to the findings from other study which found that 
knowledge is a significant predictor of adherence to 
antihypertensive treatment (Williams, Baker, Parker, & 
Nurss, 1998). However, the use of educational interventions 
to increase patients' knowledge about hypertension and the 
antihypertensive treatment have failed to show a significant 
impact on patients’ medication adherence practice (Amado 
Guirado, Pujol Ribera, Pacheco Huergo, Borras, & Grp, 
2011; Hayrettin Karaeren et al., 2009). A study of 227 
hypertensive patients in Turkey showed that having greater 
knowledge of the side effects of antihypertensive treatments 
can lead to a reduction in adherence (Karaeren et al., 2009). 
Increasing patient’s knowledge about their health condition 
and treatment may change patient’s behavior, but patients 
require time to adjust before these behavioral changes, such 
as improved adherence, can be observed (Magadza, Radloff, 
& Srinivas, 2009). 
Previous studies on antihypertensive treatment adherence 
have also assessed the impact of time since diagnosis on 
medication adherence (Caro, Salas, Speckman, Raggio, & 
Jackson, 1999; Mazzaglia et al., 2009). These studies have 
shown that newly diagnosed patients with hypertension are 
more likely to report low level of adherence to their 
treatment (Mazzaglia et al., 2009). Recently diagnosed 
patients who have started a new treatment usually experience 
the unpleasant side effects of the medication, such an 
increase in the frequency of urination or light-headedness 
which can lead to poor medication adherence. The chronic 
nature of hypertension can also impact on patients’ ability to 
adapt to the regular and long-term use of medications. Our 
study however did not find a statistically significant 
association between time since diagnosis and medication 
adherence in this population group.  
The study has several limitations that should be 
acknowledged. First, this was a small non-random sample of 
patients attending an outpatient clinic in a general hospital 
and therefore findings cannot be generalized to the overall 
population of hypertensive patients in Saudi Arabia. Second, 
this survey was based on self-reports of patients regarding 
their medication adherence and under-reporting of 
non-adherence may have occurred (although higher levels of 
non-perfect adherence were found compared to previous 
studies). A more accurate picture of non-adherence to 
antihypertensive treatment can be obtained using additional 
methods such as accessing medical and pharmacy records. 
Also, the high proportion of non-formally educated patients 
in our study could have impacted on their understanding of 
the survey questions.  
6. Conclusions 
Despite these limitations, this is the first study (to the best 
of our knowledge) that has assessed the predictors of 
medication adherence among hypertensive patients in Saudi 
Arabia. We have found that having non-formal education, 
absence of co-morbidities and a poor physician-patient 
relationship are significant predictors of non-adherence 
among this group of patients. These findings highlight the 
need for policies and interventions that enhance the level of 
formal education at a population level and improve 
physician-patient relationships in health care settings. Given 
the high prevalence of non-adherence reported in this study, 
further research is also needed to assess the feasibility and 
effectiveness of interventions that can improve treatment 
adherence among hypertensive patients in Saudi Arabia. 
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